GlobeNewswire Inc.··Mediwound Ltd.MediWound to Showcase EscharEx Data at Major Conferences as Phase III Trial Expands
MediWound to present new EscharEx clinical and preclinical data at major wound care conferences in April-May 2026, advancing Phase III trial progress and supporting expansion into new indications.
MDWDclinical dataPhase III trial